Nur Rafiqah Abdol Wahab

Mrs. Nur Rafiqah Abdol Wahab

Universiti Putra Malaysia, Seri Kembangan, Malaysia
orcid

Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
27 August 2022 in Antioxidants
Verified
Journal Article
Open access
PDF file
NWNur Rafiqah Abdol Wahab
Nur Rafiqah Abdol Wahab
MRMeor Mohd Redzuan
Meor Mohd Redzuan
SFSharida Fakurazi
Sharida Fakurazi
EAEkram Alias
Ekram Alias
HHHaniza Hassan
Haniza Hassan
Astaxanthin (3,3′-dihydroxy-4,4′-diketo-β-β carotene), which belongs to the xanthophyll class, has shown potential biological activity in in vitro and in vivo models including as a potent antioxidant, anti-lipid peroxidation and cardiovascular disease prevention agent. It is mainly extracted from an alga, Haematococcus pluvialis. As a highly lipid-soluble carotenoid, astaxanthin has been shown to have poor oral bioavailability, which limits its clinical applications. Recently, there have been several suggestions and the development of various types of nano-formulation, loaded with astaxanthin to enhance their bioavailability. The employment of nanoemulsions, liposomes, solid lipid nanoparticles, chitosan-based and PLGA-based nanoparticles as delivery vehicles of astaxanthin for nutritional supplementation purposes has proven a higher oral bioavailability of astaxanthin. In this review, we highlight the pharmacological properties, pharmacokinetics profiles and current developments of the nano-formulations of astaxanthin for its oral delivery that are believed to be beneficial for future applications. The limitations and future recommendations are also discussed in this review.

1 December 2025 in International Journal of Nanomedicine
Verified
Journal Article
Open access
PDF file
NWNur Rafiqah Abdol Wahab
Nur Rafiqah Abdol Wahab
MAMeor Mohd Redzuan Meor Mohd Affandi
Meor Mohd Redzuan Meor Mohd Affandi
SFSharida Fakurazi
Sharida Fakurazi
EAEkram Alias
Ekram Alias
HHHaniza Hassan
Haniza Hassan
Introduction: The xanthophyll carotenoid astaxanthin is well-known for its potent antioxidant properties, which are superior to those of other antioxidants such as vitamins C and E. However, this highly hydrophobic compound has low solubility and poor oral bioavailability, limiting its efficacy and clinical application. To address these pharmacokinetic challenges, nanostructured lipid carriers (NLC) have been proposed as potential lipid-based drug carriers for the oral delivery of astaxanthin owing to their excellent biocompatibility, stability, and efficient drug loading capacity. Purpose: In this study, we aimed to develop an NLC using cocoa butter and palm oil for astaxanthin encapsulation, and to optimize the nanoformulation by employing Response Surface Methodology (RSM), a statistical approach. Methods: Three-factor Central Composite Design (CCD) in RSM was used to understand the effect of independent variables on response variables. The size, polydispersity index, and encapsulation efficiency of the astaxanthin-loaded NLC were also characterized. Results: Findings of this study indicated that the mass of cocoa butter, palm oil and Tween 80 influenced the particle size, polydispersity index and zeta potential of NLC. The experimental determination of NLC did not differ significantly from the predicted RSM outcomes with size, polydispersity index and zeta potential of 254.42 ± 3.91 nm, 0.38 ± 0.01 and − 30.54 ± 0.85 mV, respectively. This nanoparticulate system showed an excellent astaxanthin entrapment efficiency of 99.69± 0.0003%. Conclusion: The ideal combination of each composition in the NLC formulation yielded nanoparticles with desirable particle size, polydispersity index, and zeta potential for efficient oral delivery of astaxanthin. Plain Language Summary: Astaxanthin is a natural antioxidant that is much stronger than vitamins C and E. However, it does not dissolve well in water and is poorly absorbed when administered orally, which limits its usefulness. To overcome this drawback, this study explored the use of nanostructured lipid carriers (NLC), which are tiny fat-based particles, to improve astaxanthin movement in the body. An NLC formulation was developed using cocoa butter and palm oil. The optimization process was conducted using a statistical method called Response Surface Methodology (RSM) to determine the best combination of ingredients. Different amounts of cocoa butter, palm oil, and a stabilizer (Tween 80) can affect the size, stability, and ability of the particles to hold astaxanthin. The results also showed that the optimized NLC had a small and uniform size (approximately 254 nm), stable dispersion (zeta potential of − 30.54 mV), and highly efficient astaxanthin trapping (99.69%). In conclusion, we successfully developed an NLC formulation that can efficiently carry astaxanthin, potentially improving its absorption and effectiveness when used as a supplement or medicine.